Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Breast Neoplasms and GSTA1[original query] |
|---|
| Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. International journal of cancer 2003 Mar 103 (6): 810-4. Sweeney Carol, Ambrosone Christine B, Joseph Lija, Stone Angie, Hutchins Laura F, Kadlubar Fred F, Coles Brian |
| Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 2006 Sep 27 (9): 1876-82. Ahn Jiyoung, Gammon Marilie D, Santella Regina M, Gaudet Mia M, Britton Julie A, Teitelbaum Susan L, Terry Mary Beth, Neugut Alfred I, Eng Sybil M, Zhang Yuesheng, Garza Cutberto, Ambrosone Christine |
| Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2008 Jun 17 (3): 225-9. Olsen Anja, Autrup Herman, Sørensen Mette, Overvad Kim, Tjønneland An |
| Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients. Journal of human genetics 2009 Oct 54 (10): 564-71. Low Siew-Kee, Kiyotani Kazuma, Mushiroda Taisei, Daigo Yataro, Nakamura Yusuke, Zembutsu Hitos |
| The role of GSTA2 polymorphisms and haplotypes in breast cancer susceptibility: a case-control study in the Portuguese population. Oncology reports 2009 Sep 22 (3): 593-8. Silva Susana N, Azevedo Ana Paula, Teixeira Valdemar, Pina Julieta Esperança, Rueff José, Gaspar Jorge Francis |
| PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environmental health perspectives 2009 Apr 117 (4): 552-8. McCarty Kathleen M, Santella Regina M, Steck Susan E, Cleveland Rebecca J, Ahn Jiyoung, Ambrosone Christine B, North Kari, Sagiv Sharon K, Eng Sybil M, Teitelbaum Susan L, Neugut Alfred I, Gammon Marilie |
| Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertility and sterility 2010 Jul 94 (2): 645-54. Su H Irene, Sammel Mary D, Velders Luke, Horn Michelle, Stankiewicz Corrie, Matro Jennifer, Gracia Clarisa R, Green Jamie, DeMichele Ange |
| Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy. Basic & clinical pharmacology & toxicology 2010 Jul 107 (1): 570-6. Afsar Nasir Ali, Haenisch Sierk, Mateen Ahmed, Usman Ahmed, Ufer Mike, Ahmed Khwaja Zafar, Ahmad Hakimuddin Razi, Cascorbi Ingo |
| Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC cancer 2011 11 (1): 291. Falvo Elisabetta, Strigari Lidia, Citro Gennaro, Giordano Carolina, Arcangeli Stefano, Soriani Antonella, D'Alessio Daniela, Muti Paola, Blandino Giovanni, Sperduti Isabella, Pinnarò Pao |
| Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Jul 23 (7): 1750-6. Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz J A, Moreno A, Román J M, Diaz-Rubio E, Caldés |
| Common variants of GSTP1, GSTA1, and TGFß1 are associated with the risk of radiation-induced fibrosis in breast cancer patients. International journal of radiation oncology, biology, physics 2012 Jun 83 (2): 504-11. Terrazzino Salvatore, La Mattina Pierdaniele, Gambaro Giuseppina, Masini Laura, Franco Pierfrancesco, Canonico Pier Luigi, Genazzani Armando A, Krengli Mar |
| Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients. European journal of clinical pharmacology 2012 Apr 68 (4): 389-95. Afsar Nasir Ali, Ufer Mike, Haenisch Sierk, Remmler Cornelia, Mateen Ahmed, Usman Ahmed, Ahmed Khwaja Zafar, Ahmad Hakimuddin Razi, Cascorbi Ingo |
| Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012 May 103 (2): 199-205. Terrazzino Salvatore, La Mattina Pierdaniele, Masini Laura, Caltavuturo Tina, Gambaro Giuseppina, Canonico Pier Luigi, Genazzani Armando A, Krengli Mar |
| Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy. Cancer research and treatment : official journal of Korean Cancer Association 2016 Jul 48 (3): 948-54. Córdoba Elisa Eugenia, Abba Martín Carlos, Lacunza Ezequiel, Fernánde Eduardo, Güerci Alba Mab |
| Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2020 6 41 (3): 447-452. Charo Lindsey M, Homer Michael V, Natarajan Loki, Haunschild Carolyn, Chung Karine, Mao Jun J, DeMichele Angela M, Su H Ire |
| Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane. The Journal of pharmacology and experimental therapeutics 2022 7 382 (3): 327-334. Teslenko Irina, Trudeau Julia, Luo Shaman, Watson Christy J W, Chen Gang, Truica Cristina I, Lazarus Phil |
| Single nucleotide polymorphisms to predict acute radiation dermatitis in breast cancer patients: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2022 3 173 103651. Aguiar Beatriz Regina Lima de, Ferreira Elaine Barros, Normando Ana Gabriela Costa, Mazzeu Juliana F, Assad Daniele Xavier, Guerra Eliete Neves Silva, Reis Paula Elaine Diniz D |
| GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients. Translational cancer research 2022 2 8 (2): 655-663. Zhang Guochun, Qian Xueke, Ren Chongyang, Wen Lingzhu, Lyu Haitong, Liao Ni |
- Page last reviewed:Feb 1, 2024
- Content source: